| Yeast expression systems: overview and recent advances R Baghban, S Farajnia, M Rajabibazl, Y Ghasemi, AA Mafi, R Hoseinpoor, ... Molecular biotechnology 61, 365-384, 2019 | 211 | 2019 |
| Bacteriophage vehicles for phage display: biology, mechanism, and application W Ebrahimizadeh, M Rajabibazl Current microbiology 69, 109-120, 2014 | 98 | 2014 |
| Isolation and characterization of protective anti-LPS nanobody against V. cholerae O1 recognizing Inaba and Ogawa serotypes W Ebrahimizadeh, S Mousavi Gargari, M Rajabibazl, L Safaee Ardekani, ... Applied microbiology and biotechnology 97, 4457-4466, 2013 | 76 | 2013 |
| A novel nanobody against urease activity of Helicobacter pylori LS Ardekani, SLM Gargari, I Rasooli, MR Bazl, M Mohammadi, ... International Journal of Infectious Diseases 17 (9), e723-e728, 2013 | 63 | 2013 |
| In vivo neutralization of botulinum neurotoxins serotype E with heavy-chain camelid antibodies (VHH) H Bakherad, SL Mousavi Gargari, I Rasooli, M RajabiBazl, M Mohammadi, ... Molecular biotechnology 55, 159-167, 2013 | 59 | 2013 |
| The applications of anti-CD20 antibodies to treat various B cells disorders Z Payandeh, AA Bahrami, R Hoseinpoor, Y Mortazavi, M Rajabibazl, ... Biomedicine & pharmacotherapy 109, 2415-2426, 2019 | 57 | 2019 |
| Humanizing glycosylation pathways in eukaryotic expression systems AH Khan, H Bayat, M Rajabibazl, S Sabri, A Rahimpour World Journal of Microbiology and Biotechnology 33, 1-12, 2017 | 51 | 2017 |
| Protein tyrosine phosphatase 1B inhibition ameliorates palmitate-induced mitochondrial dysfunction and apoptosis in skeletal muscle cells G Taheripak, S Bakhtiyari, M Rajabibazl, P Pasalar, R Meshkani Free Radical Biology and Medicine 65, 1435-1446, 2013 | 51 | 2013 |
| Regulatory T cell number in multiple sclerosis patients: A meta-analysis A Noori-Zadeh, SA Mesbah-Namin, S Bistoon-Beigloo, S Bakhtiyari, ... Multiple Sclerosis and Related Disorders 5, 73-76, 2016 | 47 | 2016 |
| Production of nanobodies against prostate-specific membrane antigen (PSMA) recognizing LnCaP cells H Zare, M Rajabibazl, I Rasooli, W Ebrahimizadeh, H Bakherad, ... The International journal of biological markers 29 (2), 169-179, 2014 | 47 | 2014 |
| A novel VHH nanobody against the active site (the CA domain) of tumor-associated, carbonic anhydrase isoform IX and its usefulness for cancer diagnosis F Araste, W Ebrahimizadeh, I Rasooli, M Rajabibazl, SL Mousavi Gargari Biotechnology letters 36, 21-28, 2014 | 44 | 2014 |
| Production of monoclonal antibody, PR81, recognizing the tandem repeat region of MUC1 mucin M Paknejad, MJ Rasaee, FK Tehrani, S Kashanian, MA Mohagheghi, ... Hybridoma and hybridomics 22 (3), 153-158, 2003 | 44 | 2003 |
| Camelid‐derived heavy‐chain nanobody against Clostridium botulinum neurotoxin E in Pichia pastoris R Baghban, SLM Gargari, M Rajabibazl, S Nazarian, H Bakherad Biotechnology and applied biochemistry 63 (2), 200-205, 2016 | 42 | 2016 |
| Production of novel VHH nanobody inhibiting angiogenesis by targeting binding site of VEGF W Ebrahimizadeh, SLM Mousavi Gargari, Z Javidan, M Rajabibazl Applied biochemistry and biotechnology 176, 1985-1995, 2015 | 42 | 2015 |
| Production of chimeric recombinant single domain antibody—green fluorescent fusion protein in Chinese hamster ovary cells MR Bazl, MJ Rasaee, M Foruzandeh, A Rahimpour, J Kiani, ... Hybridoma 26 (1), 1-9, 2007 | 38 | 2007 |
| Construction of genetically engineered M13K07 helper phage for simultaneous phage display of gold binding peptide 1 and nuclear matrix protein 22 ScFv antibody F Fatemi, SM Amini, S Kharrazi, MJ Rasaee, MA Mazlomi, ... Colloids and Surfaces B: Biointerfaces 159, 770-780, 2017 | 32 | 2017 |
| Ofatumumab monoclonal antibody affinity maturation through in silico modeling Z Payandeh, M Rajabibazl, Y Mortazavi, A Rahimpour, AH Taromchi Iranian biomedical journal 22 (3), 180, 2018 | 31 | 2018 |
| Affinity maturation and characterization of the ofatumumab monoclonal antibody Z Payandeh, M Rajabibazl, Y Mortazavi, A Rahimpour, AH Taromchi, ... Journal of cellular biochemistry 120 (1), 940-950, 2019 | 29 | 2019 |
| Immunoreaction of a recombinant nanobody from camelid single domain antibody fragment with Acinetobacter baumannii Z Payandeh, I Rasooli, SL Mousavi Gargari, M Rajabi Bazl, ... Transactions of The Royal Society of Tropical Medicine and Hygiene 108 (2 …, 2014 | 29 | 2014 |
| An overview of current drugs and prophylactic vaccines for coronavirus disease 2019 (COVID-19) A Alagheband Bahrami, A Azargoonjahromi, S Sadraei, A Aarabi, ... Cellular & molecular biology letters 27 (1), 38, 2022 | 28 | 2022 |
